Abiopharma

🔍 Silversmith Partners I GP, LLC (Executive)

Company: LifeStance Health Group, Inc. (LFST)

Report Date: 2025-08-18

Detailed Transactions and Holdings:

• Sold 3,592,357 shares of Common Stock at $5.07 per share (Direct)
  Date: 2025-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 14,324,197.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Silversmith Partners I GP, LLC is the general partner of Silversmith Partners I GP, L.P., which is the general partner of Silversmith Capital Partners I-A, L.P., Silversmith Capital Partners I-B, L.P. and Silversmith Capital Partners I-C, L.P. (collectively, the "Silversmith Entities"). Silversmith Capital Partners I-A, L.P. holds 9,855,844 shares of common stock of the Issuer, Silversmith Capital Partners I-B, L.P. holds 3,565,133 shares of common stock of the Issuer, and Silversmith Capital Partners I-C, L.P. holds 903,220 shares of common stock of the Issuer.
• F2: Each Reporting Person disclaims beneficial ownership of all of the securities that are or may be beneficially owned by the Silversmith Entities or any of their affiliates, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• F3: Silversmith Capital Partners I-A, L.P., Silversmith Capital Partners I-B, L.P. and Silversmith Capital Partners I-C, L.P. have entered into a Stockholders Agreement with certain persons who are owners of more than 10% of the Issuer's outstanding common stock and, as a result, the Silversmith Entities may be deemed a member of a "group" (as such term is used under Section 13(d) of the Securities Exchange Act of 1934, as amended) with such persons.